Formula Pharmaceuticals is Biotechnology in United States that focus on critical unmet business. Founded in 2009. They cover business area such as developer, Chimeric Antigen Receptor(CAR, critical unmet medical need, cancer, an allogeneic source, non-viral transfection, cytokine-induce killer, C.I.K., cell, Chimeric Antigen Receptor (CAR) immunotherapy platform.
2009
( 17 years old in 2026 )
Critical Unmet
-
1055 Westlakes Drive
Suite 300
Berwyn, PA 19312
United States
Private
developerChimeric Antigen Receptor(CARcritical unmet medical needcanceran allogeneic sourcenon-viral transfectioncytokine-induce killerC.I.K.cellChimeric Antigen Receptor (CAR) immunotherapy platform
* We use standard office opening hours in near Formula Pharmaceuticals's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Formula Pharmaceuticals is Biotechnology business from United States that founded in 2009 (17 years old in 2026), Formula Pharmaceuticals business is focusing on Critical Unmet.
Formula Pharmaceuticals headquarter office and corporate office address is located in 1055 Westlakes Drive Suite 300 Berwyn, PA 19312 United States.
Formula Pharmaceuticals was founded in United States.
In 2026, Formula Pharmaceuticals is currently focus on critical unmet sector.
Above is snippet of Google Trends for "critical unmet" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Formula Pharmaceuticals, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
